{
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": false,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "complex_factors": [
        "Synthetic replication",
        "Swap exposure",
        "Counterparty risk",
        "Complex index (CMCI Composite USD TR)",
        "No physical ownership of underlying assets"
    ],
    "classification": "complex",
    "supporting_data": "The product is classified as complex under MiFID II due to several key factors: 1) It uses synthetic replication via swaps to track the UBS CMCI Composite USD TR Index, meaning it does not hold physical commodities but instead relies on derivative instruments. 2) The KIID explicitly states the product is 'not simple and may be difficult to understand,' which is a strong indicator of complexity. 3) There is significant counterparty risk exposure to UBS AG, London Branch, as the issuer's inability to pay could lead to total loss of capital. 4) The underlying index (CMCI) is a composite commodity index, which inherently involves complex roll costs, contango/backwardation effects, and potential tracking error. 5) The product lacks physical ownership of the underlying assets, meaning investors have no rights to dividends or other distributions. 6) The PRIIPs KID would likely contain a comprehension warning, further signaling complexity. While the product is not leveraged or inverse, the combination of synthetic replication, swap exposure, and complex underlying index makes it unsuitable for retail investors without advanced financial knowledge.",
    "confidence": 95
}